Relay Therapeutics, Inc. ( RLAY) - Stock Earnings
RLAY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
RLAY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -54.9 million USD | 7.0 million USD |
| 2026Q1 | -73.3 million USD | 3.0 million USD |
| 2026Q2 | -83.7 million USD | 350000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RLAY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -342.0 million USD | 25.5 million USD |
| 2024 | -337.7 million USD | 10.0 million USD |
| 2025 | -276.5 million USD | 15.4 million USD |
| 2026 Est. | — | — |
RLAY
Price: $17.15
52 week price:
Earnings Per Share: -1.57 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.4 million
Market Capitalization: 4.0 billion